St. Jude receives EU clearance for cardiac mapping system

Justine Varieur Cadet | | Health Imaging | Screening
St. Jude Medical has received European CE Mark approval of its EnSite Velocity Cardiac Mapping system, which is designed to help physicians more efficiently diagnose and deliver therapy to treat abnormal heart rhythms.

With new hardware and software, the St. Paul, Minn.-based company said its system offers set-up and connections, an intuitive software interface and includes two new capabilities: the OneMap tool and RealReview function.

The OneMap tool enables physicians to create a detailed cardiac model and electrical map using multiple catheters and electrodes. The RealReview function provides real-time, side-by-side views of the live procedure and previously recorded portions of the procedure. The EnSite Velocity System is used in minimally invasive electrophysiology procedures.

Justine Varieur Cadet

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.